ProFiLE human bioavailability trial: Lutein bioavailability from a lutein-fortified sports beverage and a lutein-fortified cupcake

ISRCTN ISRCTN13108633
DOI https://doi.org/10.1186/ISRCTN13108633
Submission date
15/05/2025
Registration date
11/08/2025
Last edited
11/08/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
The Nutrition Research Centre Ireland (NRCI), based at the Southeast Technological University (SETU), is presently engaged in investigating the potential of lutein-enriched functional foods to effectively introduce lutein into the human body. This investigation was carried out by the NRCI through a bioavailability study in collaboration with Cybercolors Ltd (Fermoy, Ireland). Lutein is a micronutrient naturally found in various fruits and vegetables. It is a vital component of a balanced diet and has been scientifically proven to enhance both visual and cognitive function, with positive benefits for age-related macular degeneration (AMD), the world’s leading cause of blindness. The human body cannot produce lutein on its own, and so it must be obtained through nutrition. This is achieved by incorporating foods such as dark leafy greens and egg yolks into one's diet or by opting for dietary supplements. Recent findings indicate that the daily intake of lutein often falls short of providing the related health benefits. This confirms the huge potential for lutein fortification in functional foods. The research team have developed two functional food products fortified with lutein to support human nutrition. These food products are a sports isotonic beverage and cupcakes. This study aims to evaluate the effectiveness of lutein-fortified foods as a method to deliver lutein directly into the human body, through a bioavailability study. The study involves measuring lutein levels in the blood at different time points before and after participants eat a single serving of the lutein-fortified isotonic beverage (500 ml) or cupcake (50g).

Who can participate?
Healthy volunteers between 18-65 years of age, who were a non-smoker, non-pregnant, had no allergies i.e., gluten, eggs, dairy, no chronic disease (e.g., diabetes, cardiovascular diseases, Alzheimer’s disease, etc.), and not currently taking medication or supplements that could potentially interfere with lutein absorption.

What does the study involve?
The study spanned over five days, commencing with a 10-hour session on Day 1, held at the NRCI. Each participant was asked to consume one single serving of either the lutein fortified sport isotonic beverage or the lutein fortified cupcake. After consumption, a qualified phlebotomist withdrew blood from each participant at regular intervals throughout the day. Days 2, 3, 4 and 5 entailed one brief daily visit (15-20 minutes) to the NRCI, where a single blood sample was drawn each day. The first blood sample of each day is a fasting blood sample.

What are the possible benefits and risks of participating?
Benefits for participants are a voucher with €250 spendable in retailers. In addition, the participants could know the levels of lutein in their blood, and their overall carotenoid content at tissue level (skin carotenoid measurement).
The consumption of the lutein-enriched foods is expected to be free of side effects, as participants were pre-screened to confirm the absence of any allergies. All food products used in this trial were fully compliant with all EU food safety regulations and standards and were safe to consume.
However, it's important to note that while uncommon, the blood withdrawal procedures might carry a slight risk of side effects, including bruising, pain, bleeding, fainting, and/or dizziness.
Where is the study run from?

When is the study starting and how long is it expected to run for?
February 2024 to March 2024

Who is funding the study?
Cybercolors Ltd

Who is the main contact?
Dr Alfonso Prado-Cabrero, aprado-cabrero@wit.ie

Contact information

Dr Alfonso Prado-Cabrero
Scientific

Carriganore House, SETU West Campus, Carriganore
Waterford
X91K236
Ireland

ORCiD logoORCID ID 0000-0001-8268-5362
Phone +353 (0) 51834191
Email alfonso.prado-cabrero@setu.ie
Prof John Nolan
Public, Principal Investigator

Carriganore House, SETU West Campus, Carriganore
Waterford
X91K236
Ireland

ORCiD logoORCID ID 0000-0002-5503-7084
Phone +353 (0) 51834191
Email john.nolan@setu.ie

Study information

Study designSingle-centre interventional randomized single-dose 96-hour bioavailability human trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Laboratory
Study typeScreening
Participant information sheet 47348 ProFiLE Study_Participant information leaflet_FINAL.pdf
Scientific titleProFiLE human bioavailability trial: Lutein bioavailability from a lutein-fortified sports beverage and a lutein-fortified cupcake
Study acronymProFiLE
Study objectivesLutein is a naturally occurring carotenoid and colour pigment that is considered an antioxidant and anti-inflammatory bioactive that protects the retina and contributes to brain health. Lutein is commonly found in dark green leafy vegetables such as spinach and kale, and in fruits such as oranges and papayas. Due to the low consumption of such foods among the general population, lutein is not consumed in adequate amounts to reap its health benefits. Individuals with age-related macular degeneration (AMD) and people aiming to improve their vision and cognition consume lutein through capsules. However, children and many elderly people have swallowing difficulties. Therefore, it is desirable to develop alternative methods to increase lutein intake among the population. Functional foods offer this opportunity, as they include added bioactives among their ingredients. This human bioavailability study aimed to test the capacity of two lutein-fortified foods prepared by our group to increase the levels of lutein in the bloodstream of human participants.
Ethics approval(s)

Approved 27/02/2024, South East Technological University (SETU) Research Ethics Committee (Main Campus Cork Road, Waterford, X91 KOEK, Ireland; +353(0)51302000; Ethics.wd@setu.ie), ref: SETU/REC/23/24/001

Health condition(s) or problem(s) studiedHealthy individuals
InterventionRandom allocation sequencing was performed by the study statistician. Participants were randomly allocated to two active intervention groups, and a 5% level of significance was chosen (i.e. 95% confidence level). Participants were randomly allocated into one of the two groups:

Group 1 (10 people) consumed 500 mL of a sports beverage that has been fortified with an emulsion of the carotenoid lutein (~10 mg lutein).

Group 2 (9 people) consumed one 50-g cupcake that had been fortified with an emulsion of lutein (~10 mg lutein).

The study spanned over five days, commencing with a 10-hour session on Day 1. Each participant was asked to consume one single serving of either the lutein fortified sport isotonic beverage or the lutein fortified cupcake. After consumption, a qualified phlebotomist withdrew blood from each participant at regular intervals throughout the day. Days 2, 3, 4 and 5 entailed one brief daily visit (15-20 minutes) to the study centre, where a single blood sample was drawn each day. The first blood sample of each day is a fasting blood sample.
Intervention typeSupplement
Primary outcome measureLutein is measured using high-performance liquid chromatography with diode array detection (HPLC-DAD) at baseline, and 3, 6, 10, 24, 48, 72 and 96 hours after taking the lutein-fortified food
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date27/02/2024
Completion date27/03/2024

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants20
Total final enrolment19
Key inclusion criteria1. Healthy adults, defined as currently/historically not having a chronic disease, having no history of gastrointestinal diseases that could inhibit lutein absorption, having no current severe illnesses or infections, and having not undergone major surgery within the last 6 months
2. Aged between 18 and 65 years old
3. No food allergies
4. Not taking any medications or dietary supplements that would interfere with lutein absorption
Key exclusion criteria1. Pregnant or lactating women
2. Participants taking medications or supplements known to impact lutein absorption
3. Individuals with allergies to gluten, eggs, and dairy were excluded from the study as the intervention required participants to ingest lutein-fortified foods containing gluten (flour), eggs, and dairy ingredients (butter)
Date of first enrolment01/03/2024
Date of final enrolment27/03/2024

Locations

Countries of recruitment

  • Ireland

Study participating centre

Nutrirtion Research Centre reland
Carriganore House, SETU West Campus, Carriganore
Waterford
X91K236
Ireland

Sponsor information

South East Technological University
University/education

Cork Road
Waterford
X91KOEK
Ireland

Phone +353 (0) 818 121212
Email info@cybercolors.ie
Website https://www.setu.ie
ROR logo "ROR" https://ror.org/03fgx6868

Funders

Funder type

Industry

Cybercolors Ltd

No information available

Results and Publications

Intention to publish date15/07/2025
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in peer-reviewed journal.
IPD sharing planThe datasets generated and/or analysed during the current study are not expected to be made available (private funding).

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 27/05/2025 No Yes

Additional files

47348 ProFiLE Study_Participant information leaflet_FINAL.pdf

Editorial Notes

16/05/2025: Study's existence confirmed by the South East Technological University (SETU) Research Ethics Committee.